Globus Medical(US:GMED) ZACKSยท2025-11-05 15:15Core Viewpoint - Wall Street analysts predict that Globus Medical (GMED) will report quarterly earnings of $0.79 per share, reflecting a year-over-year decline of 4.8%, while revenues are expected to reach $733.45 million, marking a 17.2% increase compared to the same quarter last year [1]. Earnings Estimates - Over the past 30 days, the consensus EPS estimate has been revised downward by 1.3%, indicating a collective reassessment by covering analysts [2]. - Revisions to earnings estimates are crucial as they serve as significant indicators for predicting potential investor actions regarding the stock [3]. Revenue Projections - Analysts expect 'Net Sales by Product Category - Enabling Technologies' to be $40.23 million, showing a year-over-year increase of 5% [5]. - The consensus for 'Net Sales by Product Category - Musculoskeletal Solutions' is projected at $693.98 million, reflecting an 18.1% increase from the prior-year quarter [5]. - The average prediction for 'Geographic Revenues - International' is $144.37 million, indicating an 11.1% increase from the year-ago quarter [6]. - 'Geographic Revenues - United States' are forecasted to reach $589.84 million, representing a 19% increase from the prior-year quarter [6]. Stock Performance - Globus Medical shares have increased by 4% over the past month, outperforming the Zacks S&P 500 composite, which has seen a 1% increase [6]. - The company holds a Zacks Rank 3 (Hold), suggesting it is expected to closely follow overall market performance in the near term [6].